English
简体中文
Total: £ 56.28
2024-09-13 | Pages: 143 | Tables: 258
The global market for Anti Obesity Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion...
2024-09-13 | Pages: 105 | Tables: 202
The global market for Bone Morphogenetic Protein (BMP) was estimated to be worth US$ 498.1 million in 2023 and is forecast to a readjusted size of US$ 598.6 million by 2030 with a CAGR of 2.7% during the forecast period 2024-2030 North American marke...
2024-09-13 | Pages: 102 | Tables: 211
The global market for Hericium Erinaceus Extract was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. North American market for Hericium Erina...
2024-09-13 | Pages: 98 | Tables: 204
The global market for Plasma Sprayed Coatings for Medical Use was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. According to our research, ...
2024-09-13 | Pages: 97 | Tables: 209
The global market for Orthopedic Implant Coatings was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. According to our research, the global m...
2024-09-13 | Pages: 92 | Tables: 205
Enteric-coated aspirin is designed to resist dissolving and being absorbed in the stomach. As such, enteric-coated aspirin passes into the small intestine, where it's absorbed into the bloodstream. The purported goal is to prevent stomach ulcers and ...
2024-09-13 | Pages: 127 | Tables: 249
Glucose Injection solution is used in hospitalized patients for nutrition support, to treat low blood sugar, and to decrease high potassium levels in the blood. The global market for Glucose Injection was estimated to be worth US$ 3140 million in 202...
2024-09-13 | Pages: 97 | Tables: 210
A recombinant peptide therapy is produced through recombinant DNA technology. This involves inserting the DNA encoding the peptide into bacterial or mammalian cells, expressing the peptide in these cells and then purifying it from them. The global ma...
2024-09-13 | Pages: 99 | Tables: 200
Sufentanil, sold under the brand names Dsuvia and Sufenta, is a synthetic opioid analgesic drug approximately 5 to 10 times as potent as its parent drug, fentanyl, and 500 times as potent as morphine. The global market for Sufentanil (API) was estima...
2024-09-13 | Pages: 161 | Tables: 281
Micronutrients are those elements essential for plant growth which are needed in only very small (micro) quantities. These elements are sometimes called minor elements or trace elements, but use of the term micronutrient is encouraged by the American...
2024-09-13 | Pages: 133 | Tables: 252
The global market for Saffron was estimated to be worth US$ 774.8 million in 2023 and is forecast to a readjusted size of US$ 1517.4 million by 2030 with a CAGR of 9.6% during the forecast period 2024-2030 North American market for Saffron was valued...
2024-09-13 | Pages: 104 | Tables: 205
The global market for Neuroendocrine Carcinoma Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is ...
2024-09-13 | Pages: 99 | Tables: 201
The global market for Human Fibrinogen Concentrate was estimated to be worth US$ 790 million in 2023 and is forecast to a readjusted size of US$ 2137.2 million by 2030 with a CAGR of 15.5% during the forecast period 2024-2030 North American market fo...
2024-09-13 | Pages: 136 | Tables: 244
The global market for Biochemical Reagent was estimated to be worth US$ 18450 million in 2023 and is forecast to a readjusted size of US$ 31290 million by 2030 with a CAGR of 7.7% during the forecast period 2024-2030 North American market for Biochem...
2024-09-13 | Pages: 140 | Tables: 261
The global market for Influenza Drugs was estimated to be worth US$ 1707.6 million in 2023 and is forecast to a readjusted size of US$ 2151.5 million by 2030 with a CAGR of 3.3% during the forecast period 2024-2030 The global pharmaceutical market is...
